|
|
||||||||
Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania
Correspondence: For correspondence or reprints contact: Stefan H.J. Dresel, MD, Department of Radiology, University of Pennsylvania, 3700 Market St., Room 305, Philadelphia, PA 19104.
ABSTRACT
The central nervous system dopamine transporters (DAT5) and dopamine D2/D3 receptors are implicated in a variety of neurological disorders. Both sites are also targets for drug treatment. With the successful development of [99mTc]TRODAT-1, single isotope imaging studies using this ligand for DAT imaging can be complemented by additional use of 123I-labeled D2/D3 receptor ligand co-injected to assess both pre- and postsynaptic sites of the dopaminergic system simultaneously. Methods: Twelve SPECT scans of the brain were obtained in two baboons after intravenous administration of 740 MBq (20 mCi) [99mTc]-TRODAT-1 (technetium, [2-[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3,2,1]oct-2-yl]methyl](2-mercaptoethyl) amino]ethyl]-amino]ethanethiolato (3-)]- oxo-[1R-(exo-exo)]) and 185 MBq (5 mCi) [123l]iodobenzamide or [123l]iodobenzofuran. SPECT data were acquired by a triple-head gamma camera equipped with ultra-high-resolution fanbeam collimators (scan duration = 210 min). Two sets of SPECT data were obtained using energy windows of 15% centered on 140 keV for 99mTc and 10% asymmetric with a lower bound at 159 keV for 123l. After coregistration with MRI, region-of-interest analysis was performed using predefined templates from coregistered MRI. In blocking studies, baboons were pretreated with N-methyl-2ß-carbomethoxy-3ß-(4-fluorophenyl)tropane (CFT, 14 mg) or raclopride (14 mg) to block DAT or D2/D3 binding site, respectively. Results: Image quality of dual-isotope studies was similar to that obtained from single-isotope studies. When one site was blocked with CFT or raclopride, the binding of the respective ligand to the other site was not affected. Conclusion: This is the first example that clearly demonstrates the feasibility of simultaneous imaging of both pre-and postsynaptic sites of the dopaminergic system in baboons with dual-isotope SPECT studies. With or without corrections for cross-contamination of 123l into the 99mTc window, striatum-to-cerebellum ratios (target-to-nontarget) of dual-isotope experiments did not differ significantly from single-isotope experiments. This method may be a valuable and cost-effective tool for gaining comprehensive information about the dopaminergic system in one SPECT imaging session.
Key Words: dopamine transporters dopamine D2/D3 receptors SPECT imaging dual-isotope studies
This article has been cited by other articles:
![]() |
M. D. Ohlmeier, K. Peters, B. T. T. Wildt, M. Zedler, M. Ziegenbein, B. Wiese, H. M. Emrich, and U. Schneider Comorbidity of Alcohol and Substance Dependence with Attention-Deficit/Hyperactivity Disorder (ADHD) Alcohol Alcohol., March 7, 2008; (2008) agn014v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. E Schmitt, E. M. Meisenzahl, T. Frodl, C. La Fougere, K. Hahn, H- J. Moller, and S. Dresel The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1 J Psychopharmacol, September 1, 2005; 19(5): 488 - 493. [Abstract] [PDF] |
||||
![]() |
Y. K. Yang, L. Yu, T. L. Yeh, N. T. Chiu, P. S. Chen, and I H. Lee Associated Alterations of Striatal Dopamine D2/D3 Receptor and Transporter Binding in Drug-Naive Patients With Schizophrenia: A Dual-Isotope SPECT Study Am J Psychiatry, August 1, 2004; 161(8): 1496 - 1498. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |